shelter-pharma-ltd

Shelter Pharma Ltd Financials
Company Logo

Shelter Pharma Ltd Financial Statement

Shelter Pharma Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Shelter Pharma Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual40.02
Operating Expenses Annual31.33
Operating Profit Annual8.58
Interest Annual0.05
Depreciation0.25
Net Profit Annual6.20
Tax Annual2.08

Shelter Pharma Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.43
Cash Flow from Operations-1.85
Cash Flow from Investing-4.54
Cash Flow from Financing11.01
Cash Flow at the End5.04

Shelter Pharma Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)21.96
PBIT Margin (%)21.34
PBT Margin (%)-60.74
Net PROFIT Margin (%)15.49
Return On Networth / Equity (%)25.58
Return On Networth /Employed (%)33.54
Return On Assets (%)23.55
Total Debt / Equity (X)0.05
Asset Turnover Ratio (%)1.52

Shelter Pharma Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual3.58
Total Current Assets Annual29.72
Non Current Assets Annual8.20
Total Shareholders Funds Annual35.82
Total Assets Annual37.91

Shelter Pharma Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Dec 12, 2024, Shelter Pharma Ltd has a market capitalization of 56.84 Cr. Value Research classifies it as a Micro-Cap company.
Yes, Shelter Pharma Ltd is debt-free with a debt-to-equity ratio of 0.02.
In FY 2023 , Shelter Pharma Ltd recorded a total revenue of approximately 40.02 Cr marking a significant milestone in the company's financial performance.
Shelter Pharma Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately Infinity% and 0.1% annually, respectively..
Shelter Pharma Ltd's current PE ratio is 9.17.
Shelter Pharma Ltd's ROCE averaged 28.9% from the FY ending March 2022 to 2024, with a median of 22.9%. It peaked at 48.3% in March 2023, reflecting strong capital efficiency over the period..
Shelter Pharma Ltd's latest EBIT is Rs. 8.33 Cr, surpassing the average EBIT of Rs. 5.95 Cr over the 5 years..
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions